We drive growth through digital innovation
Disorders affecting the brain, such as Alzheimer’s disease, Schizophrenia, Parkinson’s, ADHD and depression, are the leading cause of disability and ill health worldwide.
More than 1,000 disorders of the brain and central nervous system result in higher costs and more hospitalisations than any other disease group, including heart disease and cancer.
Cambridge Cognition digital health technologies have the potential to transform clinical research and medical practice. We believe in using technology to improve the understanding, detection and treatment of neurological and psychiatric conditions – helping people to better manage brain health throughout life.
We are building a profitable and sustainable business through the provision of clinically meaningful and accessible tools to measure cognitive function and facilitate the development and delivery of optimal treatments and interventions to improve brain health around the world.
Our mission is to develop and market scientifically proven technologies to support researchers and healthcare professionals in improving brain health worldwide. Our unique combination of innovation, science and technology is at the forefront of digital health - from research to treatment, detection to cure.
Steven Powell, PhD
Chief Executive Officer, Cambridge Cognition
This information is disclosed pursuant to AIM Rule 26 and was last updated on 1 October 2018